Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. | NPJ Precis Oncol | 2024 | 38898118 | PubTator, text mining | PubMed |
| Management and Clinical Outcomes of Breast Cancer in Women Diagnosed with Hereditary Cancer Syndromes in a Clinic-Based Sample from Colombia. | Cancers (Basel) | 2024 | 38893140 | PubTator, text mining | PubMed |
| Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer. | J Natl Compr Canc Netw | 2024 | 38866043 | PubTator, text mining | PubMed |
| Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling. | JCO Glob Oncol | 2024 | 38843470 | PubTator, text mining | PubMed |
| RAD18 O-GlcNAcylation promotes translesion DNA synthesis and homologous recombination repair. | Cell Death Dis | 2024 | 38719812 | PubTator, text mining | PubMed |
| Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. | Oncologist | 2024 | 38716772 | PubTator, text mining | PubMed |
| Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery. | Biomedicines | 2024 | 38672070 | PubTator, text mining | PubMed |
| Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer. | JAMA Netw Open | 2024 | 38648056 | PubTator, text mining | PubMed |
| Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico. | JCO Glob Oncol | 2024 | 38635940 | PubTator, text mining | PubMed |
| RAD51C and MYST3 Mutations in a Case of Desmoid-Type Fibromatosis With No Mutation in CTNNB1 or APC. | Cureus | 2024 | 38571839 | PubTator, text mining | PubMed |
| Germline cancer susceptibility in individuals with melanoma. | J Am Acad Dermatol | 2024 | 38513832 | PubTator, text mining | PubMed |
| Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing. | JCO Precis Oncol | 2024 | 38513169 | PubTator, text mining | PubMed |
| Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study. | Breast Cancer Res Treat | 2024 | 38491334 | PubTator, text mining | PubMed |
| Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre. | Clin Genitourin Cancer | 2024 | 38461085 | PubTator, text mining | PubMed |
| Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report. | Hered Cancer Clin Pract | 2024 | 38360632 | PubTator, text mining | PubMed |
| Screening and prevention of ovarian cancer. | Med J Aust | 2024 | 38353066 | PubTator, text mining | PubMed |
| Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer. | JAMA Netw Open | 2024 | 38334999 | PubTator, text mining | PubMed |
| Variants in the first methionine of RAD51C are homologous recombination proficient due to an alternative start site. | DNA Repair (Amst) | 2024 | 38330859 | PubTator, text mining | PubMed |
| Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer. | Heliyon | 2024 | 38298632 | PubTator, text mining | PubMed |
| HBV promotes its replication by up-regulating RAD51C gene expression. | Sci Rep | 2024 | 38297111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=11